Management

Helmut Brunar
CEO

Dr. Helmut Brunar is an executive with broad experience in the pharma and biotech sector. Before joining as Viravaxx’ CEO, he managed supply chain activities at Johnson & Johnson’s COVID-19 vaccine program in The Netherlands. Prior to this, he was founder, CEO & Chairman at Axentis Pharma AG of Switzerland where within 11 years he built the company from scratch to develop and position respiratory drug candidate AX-TOBRA, a drug-device combination in the anti-infectives area.